Literature DB >> 18382143

Stabilization of measles virus for vaccine formulation.

Julian Kissmann1, Salvador F Ausar, Angela Rudolph, Chad Braun, Stephen P Cape, Robert E Sievers, Mark J Federspiel, Sangeeta B Joshi, C Russell Middaugh.   

Abstract

An attenuated live measles virus (MV) was characterized by several biophysical methods as a function of temperature and pH. Following a method developed previously, the resultant light scattering and spectroscopic data were synthesized into an empirical phase diagram that visually and simultaneously represents the entire data set. Using this empirically-based phase diagram, screening assays were developed to identify potential vaccine stabilizers. Various compounds are shown by these assays to inhibit the temperature-induced aggregation of viral particles, and also to protect the integrity of the viral envelope. Accelerated stability assays show that, upon thermal challenge, MV formulated with these excipients retains its infectivity to a significant extent. Thus, the enhanced physical stability produced by this method is shown to protect the biological activity of this important but labile vaccine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382143     DOI: 10.4161/hv.4.5.5863

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  14 in total

Review 1.  A rational, systematic approach for the development of vaccine formulations.

Authors:  Garry L Morefield
Journal:  AAPS J       Date:  2011-02-23       Impact factor: 4.009

2.  Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants.

Authors:  Kimberly J Hassett; David J Vance; Nishant K Jain; Neha Sahni; Lilia A Rabia; Megan C Cousins; Sangeeta Joshi; David B Volkin; C Russell Middaugh; Nicholas J Mantis; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2015-01-11       Impact factor: 3.534

Review 3.  Multidimensional methods for the formulation of biopharmaceuticals and vaccines.

Authors:  Nathaniel R Maddux; Sangeeta B Joshi; David B Volkin; John P Ralston; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2011-06-06       Impact factor: 3.534

4.  Stability of enveloped and nonenveloped viruses in hydrolyzed gelatin liquid formulation.

Authors:  Francois Marie Ngako Kadji; Kazuki Kotani; Hiroshi Tsukamoto; Yosuke Hiraoka; Katsuro Hagiwara
Journal:  Virol J       Date:  2022-05-27       Impact factor: 5.913

5.  Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.

Authors:  Chirasak Kusonwiriyawong; Vimolmas Lipipun; Nontima Vardhanabhuti; Qiang Zhang; Garnpimol C Ritthidej
Journal:  Pharm Res       Date:  2013-03-13       Impact factor: 4.200

6.  Measles vaccination using a microneedle patch.

Authors:  Chris Edens; Marcus L Collins; Jessica Ayers; Paul A Rota; Mark R Prausnitz
Journal:  Vaccine       Date:  2012-10-05       Impact factor: 3.641

7.  Evaluation of Host Cell Impurity Effects on the Performance of Sterile Filtration Processes for Therapeutic Viruses.

Authors:  Evan Wright; Karina Kawka; Maria Fe C Medina; David R Latulippe
Journal:  Membranes (Basel)       Date:  2022-03-24

8.  Screening vaccine formulations for biological activity using fresh human whole blood.

Authors:  Roger H Brookes; Jalil Hakimi; Yukyung Ha; Sepideh Aboutorabian; Salvador F Ausar; Manvi Hasija; Steven G Smith; Stephen M Todryk; Hazel M Dockrell; Nausheen Rahman
Journal:  Hum Vaccin Immunother       Date:  2014-01-08       Impact factor: 3.452

9.  A genetically modified rabies vaccine (ERAGS) induces protective immunity in dogs and cattle.

Authors:  Dong-Kun Yang; Ha-Hyun Kim; Seung Heon Lee; Woong-Ho Jeong; Dongseop Tark; In-Soo Cho
Journal:  Clin Exp Vaccine Res       Date:  2017-07-26

10.  Carbohydrate-based ice recrystallization inhibitors increase infectivity and thermostability of viral vectors.

Authors:  Shahrokh M Ghobadloo; Anna K Balcerzak; Ana Gargaun; Darija Muharemagic; Gleb G Mironov; Chantelle J Capicciotti; Jennie G Briard; Robert N Ben; Maxim V Berezovski
Journal:  Sci Rep       Date:  2014-07-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.